Many new drug candidates end up failing because they cause serious side effects in clinical trials even though lab tests involving cell cultures have been successful. This is a common occurrence if the cells used come from animal tissue, for example.
Bioreactor processes and cryotechnologies improve active ingredient tests using human cell cultures
